What Antimicrobial Resistance Means for Food Safety Litigation —
And Why It’s Getting More Complex
Food safety litigation has always required careful evaluation of contamination, causation, exposure, and damages. Antimicrobial resistance adds a new layer of scientific complexity — because resistant organisms may affect clinical severity, treatment response, epidemiological interpretation, and how experts evaluate whether contamination reflects an isolated event or a broader control failure. Legal teams that rely on laboratory results alone are missing most of the picture.
← Back to InsightsAntimicrobial resistance changes how food safety evidence must be interpreted in litigation — resistance data affects clinical severity, epidemiological analysis, and evaluation of facility-level control failures. Legal teams cannot rely on a positive result or resistance report alone; scientific evaluation must clarify what the evidence supports, what it does not, and where significant uncertainty remains.
Here’s the Problem
Traditional food safety litigation focuses on four core questions: was contamination present, did it cause illness, was there exposure, and what were the damages? Antimicrobial resistance does not replace those questions — it makes each one harder to answer. A resistant organism behaves differently, responds to treatment differently, and may carry epidemiological implications that change how the evidence is read.
Laboratory reports that identify a resistant pathogen are often treated as self-explanatory by legal teams. They are not. The organism identity, the specific resistance profile, the sampling methodology, and the chain of custody all influence whether a result is meaningful, ambiguous, or potentially misleading. A positive result and a resistance designation together still do not establish source, timing, causation, or facility negligence.
The risk for legal teams is that opposing experts will interpret the same data differently — and the scientific uncertainty around antimicrobial resistance creates real room for that to happen. Teams that have not had the evidence carefully evaluated before forming conclusions are vulnerable.
Why It Matters
Antimicrobial resistance introduces scientific complexity at multiple points in the litigation analysis:
- Resistant organisms may produce more severe clinical outcomes, which can affect damages analysis
- Resistance patterns can complicate treatment response and the medical causation narrative
- Epidemiological interpretation of an outbreak may change when resistance data is added to the picture
- Resistance profiles may support — or undermine — arguments about contamination source and spread
- Facility records, sanitation history, and HACCP compliance become more important when a resistant strain is identified
- Opposing experts may exploit ambiguity in resistance data to challenge causation, source attribution, or control failure arguments
Legal teams that do not have the microbiological evidence carefully interpreted before deposition or trial are forming strategy on an incomplete scientific foundation.
“A resistant pathogen in a facility sample raises questions. It does not answer them — and the questions it raises are exactly what opposing counsel will pursue.”
A Real Example: What a Resistant Salmonella Result Actually Establishes
A product or facility sample tests positive for a multidrug-resistant Salmonella strain. That result is potentially significant. It is not, by itself, sufficient to establish source, timing, exposure route, or facility-level negligence.
The sampling method determines whether the result reflects active contamination or environmental persistence. Timing determines whether the organism was present at the point of production or introduced later. Chain of custody determines whether the result is scientifically defensible. The resistance profile may indicate the organism’s likely origin or transmission route — or it may not. Facility sanitation records, HACCP documentation, corrective action logs, and product flow data are all required to evaluate whether the evidence supports a systematic control failure or an isolated event.
A strong microbiological expert does not simply confirm the result is significant. They explain what it establishes, what it does not establish, and what additional evidence would be required to support or rule out the conclusions the case depends on.
What Legal Teams Should Ask
Before relying on microbiological evidence in strategy, deposition, or trial preparation, legal teams should work through the following questions with scientific support:
| Question | Why it matters |
|---|---|
| What organism was identified? | Organism identity determines the relevant epidemiology, clinical implications, and applicable scientific literature |
| What resistance pattern was reported? | Resistance profiles vary significantly in their interpretive implications — not all resistance findings carry the same litigation weight |
| How was the sample collected? | Sampling method and location determine what the result can and cannot establish about contamination source or scope |
| Was chain of custody documented? | Breaks in chain of custody can render laboratory results scientifically indefensible under adversarial scrutiny |
| Do records support a facility-level control failure? | A positive result alone does not establish negligence — facility records and HACCP documentation are required to evaluate systemic responsibility |
| Does the evidence support causation or only association? | Association between a resistant organism and illness is not the same as established causation — the distinction is critical for both liability and damages |
What to Do
- Separate contamination evidence from causation evidence before drawing conclusions — they require different scientific analyses
- Review laboratory methods, sampling strategy, and chain of custody documentation before treating results as reliable
- Interpret resistance patterns in context — alongside organism identity, epidemiology, facility records, sanitation data, and product flow
- Evaluate whether the available evidence supports an isolated contamination event or a broader food safety control failure
- Identify gaps and vulnerabilities in opposing expert conclusions before deposition or trial, not during
- Engage microbiology expertise early enough to shape document requests, evidence review, and case strategy from the outset
Antimicrobial resistance should never be interpreted in isolation. Its significance in litigation depends entirely on the organism involved, the facility’s control systems, the sampling context, the epidemiological record, and the limits of what the available evidence can actually establish. Without that interpretive work, resistance data is as likely to create confusion as it is to clarify.
- Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. U.S. Department of Health and Human Services, 2019.
- World Health Organization. Global Action Plan on Antimicrobial Resistance. WHO, 2015.
- Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States — major pathogens. Emerging Infectious Diseases. 2011;17(1):7–15.
- U.S. Food & Drug Administration. FSMA Final Rule for Preventive Controls for Human Food. FDA, 2015.
Five things this article establishes
- 1 Antimicrobial resistance adds a significant layer of scientific complexity to food safety litigation — one that changes how evidence must be evaluated at every stage.
- 2 Resistance data rarely speaks for itself and must be interpreted in context — organism identity, sampling method, facility records, and epidemiology all matter.
- 3 A positive laboratory result does not automatically establish contamination source, causation, or facility-level control failure.
- 4 Strong microbiological evaluation connects laboratory findings with facility records, sanitation data, epidemiology, and the limits of what the evidence can actually support.
- 5 Legal teams benefit most from experts who can explain both what the microbiological evidence supports — and where it falls short of the conclusions the case may require.
Explore our scientific services
Browse the full range of FSC’s independent scientific consulting services and resources.
Explore Our Services